Table 1 Sample characteristics.
Sample cohort (n) | ΔT (days) post-complete vaccination (mean, SD) | ΔT (days) between doses (mean, SD) | Age (years), median (IQR) | Sex (n, %) | |
|---|---|---|---|---|---|
Female | Male | ||||
one-dose Ad26.CoV2.S (23) | 53.8 (17.1) | na | 61 (53–68) | 14 (60.9) | 9 (39.1) |
two-dose AZD1222 (25) | 28.7 (2.7) | 76.7 (3.1) | 64 (62–66) | 14 (56.0) | 11 (44.0) |
first dose AZD1222, second dose BNT162b2 (25) | 25.3 (6.1) | 70.8 (16.8) | 67 (57–70) | 11 (44.0) | 14 (56.0) |
first dose AZD1222, second dose mRNA-1273 (24) | 23.2 (12.8) | 69.6 (16.9) | 68 (65–71) | 15 (62.5) | 9 (37.5) |
two-dose mRNA-1273 (24) | 31.7 (5.6) | 30.7 (5.4) | 56 (54–69) | 15 (62.5) | 9 (37.5) |
two-dose BNT162b2 T1 * (23) | 29.5 (7.3) | 21.2 (1.0) | 51 (41–58) | 18 (78.3) | 5 (21.7) |
two-dose BNT162b2 T2 * (23) | 174.0 (14.2) | ||||
